Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence
Public ClinicalTrials.gov record NCT00687713. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is to assess the efficacy of bupropion in reducing methamphetamine use in subjects with methamphetamine dependence who report using methamphetamine 29 or less days during the 30 days prior to the start of signing consent.
Study identification
- NCT ID
- NCT00687713
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2008 (Type not available)
- Primary completion
- May 2011 (Actual)
- Completion
- May 2011 (Actual)
- Last update posted
- Mar 21, 2017
2008 – 2011
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA Integrated Substance Abuse Program | Los Angeles | California | 90025 | — |
| South Bay Treatment Center | San Diego | California | 92115 | — |
| Addiction and Pharmacology Research Laboratory | San Francisco | California | 94110 | — |
| Friends Research Institute | Torrance | California | 90502 | — |
| Matrix Institute | Woodland Hills | California | 91364 | — |
| Pacific Addiction Research Center - U of Hawaii | Honolulu | Hawaii | 96817 | — |
| Iowa Luther Hospital | Des Moines | Iowa | 50316 | — |
| U of Kansas Medical Center | Kansas City | Missouri | 64131 | — |
| New York University | New York | New York | 10010 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| University of Texas Health Science At San Antonio | San Antonio | Texas | 78229-3900 | — |
| VA Salt Lake City Health Care System | Salt Lake City | Utah | 84148 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00687713, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 21, 2017 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00687713 live on ClinicalTrials.gov.